Healthy high growth potential

Results

1478

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1478 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
325
HK$41.56-4.6%-70.6%HK$10.3bHK$81.0014.122.7%n/aConsumer Durables
2480
HK$12.810.08%-47.0%HK$2.5bHK$31.003.377.1%n/aPharmaceuticals & Biotech
1729
HK$16.92-12.7%128.0%HK$37.8bHK$25.0048.233.6%0.3%Capital Goods
6223
NT$6,090.00-8.8%547.9%NT$596.7bNT$7,502.73162.155.5%0.4%Semiconductors
1357
HK$3.75-6.9%-58.5%HK$17.1bHK$9.3220.231.4%2.7%Media
1860
HK$10.13-12.7%42.7%HK$15.6bHK$18.2626.641.1%n/aMedia
2315
HK$46.7412.6%107.7%HK$47.6bHK$62.0262.340.4%n/aPharmaceuticals & Biotech
6990
HK$436.209.6%33.3%HK$101.7bHK$547.6442.844.8%n/aPharmaceuticals & Biotech
2171
HK$14.26-9.5%-38.3%HK$8.5bHK$21.1458.480.6%n/aPharmaceuticals & Biotech
3881
HK$20.32-11.6%n/aHK$8.9bn/a8.7107.6%n/aCapital Goods
3636
HK$15.30-1.4%n/aHK$2.3bHK$31.206.140.2%2.5%Materials
KEBNI B
SEK 1.16-9.5%-42.8%SEK 317.6mSEK 1.602.882.7%n/aTech
FWRY
ج.م18.40-2.4%52.7%ج.م62.7bج.م22.4523.627.3%n/aDiversified Financials
CDR
zł224.40-1.9%-18.7%zł22.4bzł235.1343.429.4%0.4%Media
MDGL
US$536.954.6%78.9%US$12.2bUS$678.7110.959.2%n/aPharmaceuticals & Biotech
AGP
€6.98-2.1%-11.4%€127.3m€8.5725.637.8%n/aCapital Goods
4417
JP¥3,805.0018.9%26.0%JP¥57.9bJP¥4,500.0038.524.1%0.9%Software
CORT
US$86.958.9%25.5%US$9.4bUS$88.00200.048.9%n/aPharmaceuticals & Biotech
6787
JP¥29,350.00-9.4%354.3%JP¥795.7bJP¥26,066.6738.727.3%0.5%Tech
2368
NT$1,225.00-2.4%321.7%NT$606.5bNT$1,485.0054.638.2%0.8%Tech
9218
JP¥726.003.3%11.2%JP¥7.6bn/a32.128.9%1.4%Healthcare
7685
JP¥3,285.00-8.1%125.0%JP¥203.7bJP¥4,666.6727.625.5%0.7%Retail
456A
JP¥1,356.00-8.9%n/aJP¥138.1bn/a38.423.4%n/aRetail
7769
NT$6,905.002.2%402.2%NT$1.2tNT$9,322.7186.243.7%0.9%Semiconductors
Page 1 of 42